Apyx Medical Corporation
APYX • NASDAQ
Apyx Medical Corporation is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Charles D. Goodwin, with a market cap of $152.3M.
CEOCharles D. Goodwin
Next Earnings
Upcoming earnings announcement for Apyx Medical Corporation
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.11
Revenue Estimate
$11.2M
Earnings History
Past 12 earnings reports for Apyx Medical Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.03Est: -$0.06 | +50.0% | $19.2MEst: $19.1M | +0.2% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.05Est: -$0.10 | +50.0% | $12.9MEst: $12.0M | +7.3% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.09Est: -$0.09 | 0.0% | $11.4MEst: $11.7M | -2.8% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.10Est: -$0.12 | +16.7% | $9.4MEst: $9.4M | +0.5% | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.12Est: -$0.16 | +25.0% | $14.2MEst: $13.4M | +6.2% | 10-K |
| Nov 8, 2024 | Q3 2024 | -$0.14Est: -$0.19 | +26.3% | $11.5MEst: $11.4M | +0.9% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.19Est: -$0.20 | +5.0% | $12.1MEst: $11.8M | +3.4% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.22Est: -$0.21 | -4.8% | $10.2MEst: $9.5M | +7.5% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.28Est: -$0.18 | -55.6% | $14.7MEst: $14.9M | -1.3% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.13Est: -$0.11 | -18.2% | $12.0MEst: $15.4M | -22.1% | — |
| Aug 10, 2023 | Q2 2023 | -$0.11Est: -$0.07 | -57.1% | $13.6MEst: $14.3M | -5.2% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.10Est: -$0.13 | +23.1% | $12.1MEst: $10.9M | +11.7% | — |